Pharmafile Logo
Pharmafocus logo
Advanced Search

UK-funded science research must be made more accessible, says minister

September 16, 2011
Medical Communications, Research and Development UK science

Research paid for by the UK taxpayer must be made more accessible to the public, researchers and other stake holders, …

News

Positive results for phase II malaria vaccine

September 16, 2011
Research and Development malaria, malaria vaccine

Researchers in the US and West Africa believe they have identified the first effective blood-stage malaria vaccine, a development which …

News

Edelman appoints new head of digital health

September 16, 2011
Medical Communications appointment, medical communications

Edelman has appointed Dave Pinnington as head of digital health for Europe to lead the development of the PR firm’s …

Appointment

Firstlight launches new health offering

September 16, 2011
Medical Communications Firstlight, medical communications news

London-based PR agency Firstlight has set up a new healthcare arm and appointed Pat Pearson to lead it. He is …

News
Merck & Co

Merck’s COPD drug rejected by NICE

September 15, 2011
Sales and Marketing Daxas, MSD, Merck & Co, NICE, roflumilast

NICE has not recommended Merck Co’s Daxas and has advised the firm to conduct a clinical trial in order to …

News

Designing clinical trials for the real world

September 15, 2011
Research and Development clinical trials

A few years ago I was dealing with a big CRO which had been commissioned to run a pharmacokinetics (PK) …

Feature
almirall_alfredo_baron

Almirall promotes Alfredo Barón

September 15, 2011
Sales and Marketing appointment, sales and marketing

Spanish pharma company Almirall has promoted Alfredo Barón to area director for Southern and Eastern Europe. He has been with the …

Appointment

Fresh scrutiny for new diabetes drugs

September 15, 2011
Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes

Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …

News

Daiichi Sankyo subsidiary gets FDA warning

September 15, 2011
Daiichi Sankyo, FDA, Luitpold

Daiichi Sankyo’s US subsidiary Luitpold Pharmaceuticals has been sent a warning letter by the FDA for “significant” and repeated quality …

News
Blog footer

Digital Pharma: Lilly plans social media expansion

September 14, 2011
Medical Communications Digital Pharma blog, Facebook, lilly, social media, youtube

One year after launching its corporate blog Lilly is ramping up its use of social media. Last week the company …

News

First Paediatric Use Marketing Authorisation Granted

September 14, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Commission has granted the first ever children’s medicine to hold a new Paediatric Use Marketing Authorisation (PUMA). The …

News
Press release

GSK-Merck back new developing world cancer charity

September 14, 2011
Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer

GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …

News
Merck & Co

Merck collaborates with China-based genomics specialist BGI

September 14, 2011
Research and Development BGI, Merck & Co, biomarkers, genomics

Scientists from Merck & Co and China-based genomics specialist BGI are to work together to find and develop biomarkers and …

News
US Food and Drug Administration

FDA unveils changes to cancer drug review

September 14, 2011
Research and Development, Sales and Marketing Cancer, FDA, regulatory affairs

The FDA has unveiled a reorganisation of how it reviews new cancer drugs, and says the new approach should help …

News
GlaxoSmithKline

GSK-Amicus start late-stage trials of Fabry disease treatment

September 14, 2011
Research and Development Amicus Therapeutics, Fabry disease, GSK

GlaxoSmithKline and Amicus Therapeutics are moving forward with their phase III programme for Fabry disease treatment Amigal. The first patient …

News

Novartis loses global development head to Gates Foundation

September 14, 2011
Research and Development Bill and Melinda Gates Foundation, Novartis, appointment

Novartis’ global head of development Trevor Mundel is to leave the company and take a senior position at The Bill …

News

Government bites the bullet over A&E closure

September 14, 2011
NHS, NHS reform, hosptials

The government has backed the closure of the Accident and Emergency department at Chase Farm hospital in London, ending years …

News

The recast of the Restriction of Hazardous Substances (RoHS) Directive

September 13, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The recast Directive on the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU) will …

News
Press release
Novo Nordisk's Victoza (liraglutide)

Victoza data shows promise for early setting

September 13, 2011
Research and Development, Sales and Marketing Novo Nordisk, Victoza

New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …

News
Shanghai China flag

Betting big on research in China

September 13, 2011
Manufacturing and Production, Research and Development China, R&D

For eighteen out of the last twenty centuries, China has stood as the world’s most innovative and largest economy – …

Feature
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026